JDD Buzz Series | GLP-1 Agonists and Isotretinoin
GLP-1 Agonists and IsotretinoinUse of GLP-1 agonists is becoming increasingly more common in the U.S. According to a 2024 poll, one in eight adults has at least tried this medication class. A brief communication published in the June Journal of Drugs in Dermatology shares concerns that could arise when a patient is concurrently on a GLP-1 agonist and isotretinoin. I interviewed author Travis W. Blalock, MD, FAAD, FACMS, dire …
GLP-1 Agonists and Isotretinoin
Dark Spot Actives, Vitamin A Derivatives, and Cleansers: A Brief Review
Vitamin ALeslie Rank, PhD, Global Product Development Lead of Facial Treatment Products, and Rachel Bechtel, Senior Scientist on the Facial Cleansing Product & Process Innovation Team at Kenvue, spoke to dermatology residents at The George Washington University’s first Lab to Label Conference, about the formulation of popular products including dark spot actives, vitamin A derivatives, and cleansers. …
Vitamin A
Pediatric Dermatology: Educational Opportunities for Residents
Pediatric DermatologyPediatric dermatology exposure varies widely between residency programs. While some residents may plan to pursue a pediatric dermatology fellowship, the majority will not. Despite this, most dermatologists will see a mixture of children and adolescents in their clinic. Whether you plan to focus on complex medical dermatology, general dermatology, procedural work, or anything in between, developing …
Pediatric Dermatology
JDD Buzz Series | AI in Dermatology Residency Applications: A Program Director’s Perspective
AI in dermatologyApplicants for dermatology residency programs are increasingly using artificial intelligence (AI) technology to write or enhance their personal statements, according to a study published in the May Journal of Drugs in Dermatology. Is this ethical? Should applicants disclose AI usage? What role, if any, should AI have in applications for programs, positions, and grants? I interviewed Marjorie Mo …
AI in dermatology